12/15/23 – 12/17/2023

VALIS Hotel, Volos

IASIS PHARMA participated in the HELLENIC OSTEOPOROSIS FOUNDATION CONFERENCE (HELIOS), held in Volos, at the Valis Hotel, from December 15 to 17, 2023.

Τhe annual conference of the Hellenic Osteoporosis Foundation (ΗELIOS) is the main scientific event of the HELIOS Foundation since 1996, involving participations of medical specialties dealing with Osteoporosis and Metabolic Diseases, in order to be informed about the latest developments in the subjects of metabolic bone diseases.

During the conference, IASIS PHARMA organized a Satellite Lecture, entitled:

“The Role of The Fixed Combination οf Alendronate & Vitamin D3 In The Treatment οf Osteoporosis”.

Chair person: Dr Anastasilakis A., Endocrinologist at 424 General Military Hospital Thessaloniki, Greece.

Speaker: Dr Kosmidis Ch., Orthopedic Surgeon, University of Athens.

In IASIS PHARMA exhibition stand, the following products were presented:

• COVED®: Alendronic Acid 70mg/ Cholecalciferol 5.600IU, (box of 40 tabs) for monthly treatment.
• Etrozac®: Etoricoxib: Etrozac® 20 tabs x 60 mg, Etrozac® 14 tabs x 90 mg, Etrozac® 20 tabs x 90 mg, Etrozac® 20 tabs x 120 mg.
• Calciform D3®: (Box of 30 eff. tabs).
• Mag/IASIS®/ 243 mg Μαγνησίου, 243 mg Magnesium, (Box of 40 eff. tabs).